LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 27.49 | 27.76 | 4 | 1723 | 0.0023 | -0.2777 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 27.49 | 27.76 | 1148 | 1723 | 0.6662 | 0.8682 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 27.49 | 27.76 | 48 | 1723 | 0.0279 | 0.0963 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 27.49 | 27.76 | 1730 | 1723 | 1.0040 | 1.0013 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 29.19 | 27.76 | 5 | 1863 | 0.0027 | -0.2461 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 29.19 | 27.76 | 1275 | 1863 | 0.6843 | 0.8788 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 29.19 | 27.76 | 54 | 1863 | 0.0290 | 0.1159 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 29.19 | 27.76 | 1852 | 1863 | 0.9940 | 0.9980 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 30.90 | 27.76 | 4 | 2032 | 0.0020 | -0.2686 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 30.90 | 27.76 | 1470 | 2032 | 0.7233 | 0.8981 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 30.90 | 27.76 | 107 | 2032 | 0.0526 | 0.2434 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 30.90 | 27.76 | 1971 | 2032 | 0.9698 | 0.9901 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 32.60 | 27.76 | 11 | 2235 | 0.0049 | -0.1360 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 32.60 | 27.76 | 1726 | 2235 | 0.7720 | 0.9199 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 32.60 | 27.76 | 117 | 2235 | 0.0523 | 0.2551 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 32.60 | 27.76 | 2132 | 2235 | 0.9536 | 0.9850 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 34.30 | 27.76 | 4 | 2449 | 0.0016 | -0.2590 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 34.30 | 27.76 | 1889 | 2449 | 0.7711 | 0.9212 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 34.30 | 27.76 | 133 | 2449 | 0.0543 | 0.2743 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 34.30 | 27.76 | 2353 | 2449 | 0.9605 | 0.9876 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 36.01 | 27.76 | 9 | 2662 | 0.0034 | -0.1572 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 36.01 | 27.76 | 2190 | 2662 | 0.8224 | 0.9415 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 36.01 | 27.76 | 190 | 2662 | 0.0714 | 0.3393 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 36.01 | 27.76 | 2532 | 2662 | 0.9508 | 0.9847 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 37.71 | 27.76 | 7 | 2877 | 0.0024 | -0.1860 | MN20160318_Q01 | C22 |